MTCR लाइव सिग्नल्स | Getagraph.com के साथ लाभ को अधिकतम करें

Live Chart Being Loaded With Signals

Commentary (21 Jun 2023 @ 00:41):

Metacrine, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing therapies for patients with gastrointestinal diseases...

Stats
आज की मात्रा	83 889.00
औसत मात्रा	52 473.00
बाजार मूल्य	25.48M
EPS	$0 ( 2023-11-13 )
Last Dividend	$0.580 ( 2023-06-21 )
Next Dividend	$0 ( N/A )
P/E	-0.564
ATR14	$0.0160 (2.75%)

Insider Trading

Date	Person	Action	Amount	type
2023-03-23	Klassen Preston	Sell	842 211	Common Stock
2023-03-23	Klassen Preston	Sell	842 211	Stock Option (right to buy)
2023-01-26	York Michael	Sell	107 054	Common Stock
2023-01-26	Klassen Preston	Sell	380 605	Common Stock
2022-12-21	Leonard Braden Michael	Buy	120 099	Common Stock

INSIDER POWER
-17.12
Last 97 transactions
Buy: 12 877 287 \| Sell: 12 262 808

मात्रा सहसंबंध

लंबा: -0.64 (weak negative)

छोटा: 0.81 (strong)

Signal:(57.111) Same movement expected

Metacrine, Inc. सहसंबंध

10 सबसे अधिक सकारात्मक सहसंबंध
LMRK	0.865
KNBE	0.855
AFBI	0.834
OCAX	0.833
IMRA	0.83
AGFS	0.83
QADA	0.827
XOMAO	0.824
EYEG	0.821
STTK	0.817

10 सबसे अधिक नकारात्मक सहसंबंध
GNUS	-0.872
AGIL	-0.858
CNEY	-0.858
UTRS	-0.857
TANH	-0.855
MOTS	-0.851
BLUE	-0.849
PCSA	-0.844
ADN	-0.829
BJDX	-0.827

क्या आप जानते हैं?

कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।

कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।

Metacrine, Inc. सहसंबंध - मुद्रा/वस्त्र

-0.04
( neutral )

-0.52
( weak negative )

0.00
( neutral )

0.67
( moderate )

0.68
( moderate )

Metacrine, Inc. वित्तीय

Annual	2021
राजस्व:	$0.00
सकल लाभ:	$0.00 (0.00 %)
EPS:	$-2.40

FY	2021
राजस्व:	$0.00
सकल लाभ:	$0.00 (0.00 %)
EPS:	$-2.40

FY	2020
राजस्व:	$0.00
सकल लाभ:	$0.00 (0.00 %)
EPS:	$-1.436

FY	2019
राजस्व:	$0.00
सकल लाभ:	$0.00 (0.00 %)
EPS:	$-1.520

Financial Reports:

No articles found.

Metacrine, Inc. Dividends

(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0.580 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Metacrine, Inc. Dividend Information - Dividend Knight

Dividend Sustainability Score: 0 - N/A | Divividend Growth Potential Score: 0 - N/A

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.580	2023-06-21
Last Dividend	$0.580	2023-06-21
Next Dividend	$0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	1	--
Total Paid Out	$0.580	--
Avg. Dividend % Per Year	43.27%	--
Score	4.01	--
Div. Sustainability Score	0
Div.Growth Potential Score	0
Div. Directional Score	0	--

Next Divdend (Est)
(2024-05-08)

$1.160 Estimate 2.50 %

Dividend Stability

0.20 Very Poor

Dividend Score

4.01

Pay Frequency

Insufficient data to determine frequency

Yearly Payout

Year	Amount	Yield
2023	$0.580	129.80%
2024	$0	0.00%

Dividend Commentary

Unable to generate commentary due to missing data.

Top 10 dividend Companies for NASDAQ

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
PSEC	Dividend Royal	2023-12-26	Monthly	21	7.04%	8.50
SLVO	Dividend Royal	2023-11-20	Monthly	12	10.77%	8.50
QYLD	Dividend Royal	2023-11-20	Monthly	11	7.50%	8.50
GAIN	Dividend Royal	2023-12-04	Monthly	20	8.19%	8.50
GLDI	Dividend Royal	2023-11-20	Monthly	12	7.15%	8.50
OXLC	Dividend Royal	2023-12-14	Monthly	14	10.00%	8.50
OXSQ	Dividend Royal	2023-12-14	Monthly	21	9.10%	8.50
HRZN	Dividend King	2023-12-18	Monthly	15	6.60%	8.45
USOI	Dividend Royal	2023-11-20	Monthly	8	16.70%	8.28
PFLT	Dividend King	2023-11-15	Monthly	14	6.50%	8.27

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0	1.500	0	0	[0 - 0.5]
returnOnAssetsTTM	-0.766	1.200	-10.00	-10.00	[0 - 0.3]
returnOnEquityTTM	-0.835	1.500	-10.00	-10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	10.15	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	13.40	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	9.85	1.500	10.00	10.00	[0.2 - 2]
debtRatioTTM	0.177	-1.500	7.06	-10.00	[0 - 0.6]
interestCoverageTTM	-50.81	1.000	-10.00	-10.00	[3 - 30]
operatingCashFlowPerShareTTM	-1.120	2.00	-0.373	-0.747	[0 - 30]
freeCashFlowPerShareTTM	-1.120	2.00	-0.560	-1.120	[0 - 20]
debtEquityRatioTTM	0.246	-1.500	9.01	-10.00	[0 - 2.5]
grossProfitMarginTTM	0	1.000	-3.33	-3.33	[0.2 - 0.8]
operatingProfitMarginTTM	0	1.000	-2.00	-2.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	-3.34	1.000	-10.00	-10.00	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				-0.578

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-0.400	1.000	-0.141	0	[1 - 100]
returnOnEquityTTM	-0.835	2.50	-6.68	-10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	-1.120	2.00	-0.373	-1.120	[0 - 30]
dividendYielPercentageTTM	99.76	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-1.120	2.00	-0.373	-0.747	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0	1.500	-3.33	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0	1.000	-2.50	0	[0.1 - 0.5]
Total Score				-0.413

Metacrine, Inc.

Metacrine, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing therapies for patients with gastrointestinal diseases. It is developing MET642, which has completed Phase I clinical trial for the treatment of ulcerative colitis. Metacrine, Inc. was incorporated in 2014 and is headquartered in San Diego, California.